Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(
1
)
Home
|
Portfolio
|
Market Currents
|
Investing Ideas
|
Dividends & Income
|
ETFs
|
Macro View
|
ALERTS
|
PRO
This Market Current was sent to
1,636
people who get email alerts on ONXX.
Get email alerts on ONXX »
Market Currents
All
Top Stories
Breaking News
On the Move
Quick Ideas
Earnings
Dividends
M&A
U.S. Economy
Global & FX
Commodities
ETFs
Tech
Consumer
Energy
Financials
Healthcare
Onyx Pharmaceuticals (ONXX) resumes trading, +9.6% to $75.
Friday, July 20, 2012, 12:58 PM ET
Onyx Pharmaceuticals (
ONXX
) resumes trading,
+9.6%
to $75.
This Market Current was sent to
1,636
people who get email alerts on ONXX.
Get email alerts on ONXX »
Share this Market Current
Short URL:
Tweet
Load All Comments
LATEST
|
TODAY SO FAR
|
YESTERDAY
Other date
DJIA (
DIA
)
S&P 500 (
SPY
)
HEALTHCARE ETF
s
IN FOCUS
Latest Healthcare Articles
The Long Case For WellCare Health
6:05 PM
•
Unbigoted Research
Cipher Banking On Absorica, Literally
5:08 PM
•
Jason Napodano
Obesity Sector Gets New Shoes
5:01 PM
•
John Reisman
Why PharmAthene Will Win Its Suit With Siga And How Much It Will Collect
4:40 PM
•
Jeff Eiseman
Is ANCHOR Do Or Die For Amarin?
2:24 PM
•
Quoth the Raven
3 Biotechs With Strong Momentum - Can They Keep It Up?
1:40 PM
•
Craig Keolanui
Galena Biopharma: David Battles Goliath
1:04 PM
•
Regarded Solutions
Medivation's Competitor Was Just Acquired, But It's Not As Bad As It Sounds
12:29 PM
•
PropThink
The Neuralstem You Don't Know
11:49 AM
•
Jason Napodano
Sarepta Therapeutics Remains A Strong Buy
10:56 AM
•
Carl Cachia
Medivation's Xtandi Threatened By Johnson & Johnson's New Acquisition
10:40 AM
•
Brian L. Wilson
Wednesday's Small Cap Biotech Catalyst Watch And Trade List
9:29 AM
•
StockMatusow
Amgen In Focus
9:13 AM
•
XY Trader
Johnson & Johnson: Aragon Pharmaceuticals Is An Excellent Addition For Its Oncology Unit
9:02 AM
•
The Value Investor
Eli Lilly: Cymbalta Antidepressant Sales Forecast
8:46 AM
•
Pharma Reports
More Latest Articles »